VIA EDGAR SUBMISSION AND FEDERAL EXPRESS

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

Attention:	Mr. Martin James, Senior Assistant Chief Accountant

Re:	Roper Industries, Inc. Form 10-K for the Year Ended December 31, 2013 Filed February 21, 2014 File No. 001-12273

Dear Mr. James:

This letter responds to the comments of the Staff (the "Staff") of the Securities and Exchange Commission (the "Commission") to Mr. John Humphrey, Roper Industries, Inc. (the "Company") in the letter dated April 1, 2014 (the "Comment Letter") regarding the above-referenced Form 10-K for the Company's fiscal year ended December 31, 2013 and the Form 8-K dated January 27, 2014.

Set forth below are the Staff's comments (in bold) and the Company's responses thereto, organized as set forth in the Comment Letter.

Form 10-K for the Year Ended December 31, 2013

Item 7. Management Discussion and Analysis of Financial Condition and Results of Operations

Application of Critical Accounting Policies

With respect to your disclosures regarding goodwill impairment testing, you disclose that the fair value of one of your reporting units in the RF Technology segment was less than 5% above its carrying value using a discounted cash flow methodology. For any reporting units where the fair value does not substantially exceed the carrying value, please revise future filings to provide expanded disclosure. In this regard, disclose the amount of goodwill allocated to the reporting unit, the degree of uncertainty associated with key assumptions and a description of potential events and/or changes in circumstances that could reasonably be expected to negatively affect the key assumptions. Please provide us with any proposed revised disclosures.

We respectfully clarify that our disclosures regarding goodwill impairment testing include information on our use of both an income approach (discounted cash flows) and a market approach consisting of a comparable company earnings multiples methodology to estimate the fair value of a reporting unit. We further disclose that we believe the market value of the RF Technology unit in question to be significantly in excess of its carrying value based upon observed market data. While we respect and utilize both valuation methods, we do believe the market approach to be more representative of the valuation methods we utilize in evaluating purchase prices of acquisitions. Therefore, taking into consideration both approaches, we believe the fair value of the unit does substantially exceed its carrying value, and additional disclosures were not required.

Specifically, $318 million was allocated to goodwill for this reporting unit. Key assumptions used in the formulation of our fair value estimates are the underlying growth rate of the business, anticipated future cash flows, interest rates and market multiples for comparable companies. Potential events that could negatively affect these assumptions are customer losses, decreases in price or margin performance, increases in working capital needs, a stock market decline that would lead to lower multiples for comparable companies or a general increase in interest rates, which would affect the discount rate used.

In future filings, if the fair value of a unit does not substantially exceed the carrying value based on our analysis, the Company will include expanded disclosures including the amount of goodwill allocated to the reporting unit, the degree of uncertainty associated with key assumptions and a description of potential events and/or changes in circumstances that could reasonably be expected to negatively affect the key assumptions.

Item 8. Financial Statements

Note 2. Business Acquisitions

We note your disclosure that you did not provide supplemental pro forma information for the 2013 acquisitions because the acquisitions did not have a material impact on your results of operations. We further note from your MD&A disclosures for 2013 vs. 2012 under results of operations that sales in your Medical and Scientific Imaging segment were positively impacted by $208 million due to acquisitions. Please provide us with your analysis which demonstrates that the supplemental information is not material, and explain why no additional disclosures are required under FASB ASC 805-10-50-2 (h)

The Company respectfully clarifies that the positive impact of $208 million in the Company's Medical and Scientific Imaging segment for 2013 as compared to 2012 is related to the Company's 2012 acquisition of Sunquest Information Systems, Inc ("Sunquest") and 2013 acquisition of Managed Healthcare Associates, Inc ("MHA"). Approximately $147 million of the $208 million impact was related to a full year of sales from Sunquest during 2013. As the acquisition of Sunquest was considered material, and Sunquest is a significant subsidiary, the related required disclosures were made in connection with the acquisition.

In response to the Staff's comment, the Company respectfully submits that our 2013 acquisitions were not material to its financial statements taken as a whole. Accordingly, the Company believes that the disclosure requirements of ASC 805-10-50-2(h)(2) and (h)(3) are not required in this situation. In this regard, the Company advises the Staff as follows:

·	The net sales from our 2013 acquisitions as a percentage of the Company's consolidated net sales for the year ended December 31, 2012 was 5.1%;

·	The income from continuing operations of our 2013 acquisitions as a percentage of the Company's consolidated income from continuing operations for the year ended December 31, 2012 was 2.6%;

·	The proportionate share of the total assets acquired in our 2013 acquisitions as a percentage of the Company's total consolidated assets as of December 31, 2012 was 9.2%;

·	The Company's investment in 2013 acquisitions as a percentage of the Company's total consolidated assets as of December 31, 2012 was 14.1%; and

·	The Company's acquisitions in 2013 required no new or modified borrowings;

The Company also considered other qualitative factors under ASC 805 to assess the materiality of our 2013 acquisitions including the perception of historical acquisitions, the impact on cash flows, and the effect on loan covenants or other contractual requirements.

As a related matter we note the significance of your purchase price allocation to goodwill. Please revise future filings to describe the factors that led to such a significant allocation or tell us why a revision to future filings is not necessary. Refer to FASB ASC 805-30-50-1(a).

The Company respectfully acknowledges that when significant allocations of purchase price to goodwill exist in future filings, the factors that led to such allocation will be described. The Company generally purchases high margin, asset light businesses without significant identifiable tangible or intangible assets to which we can allocate a significant portion of the purchase price. Accordingly, these acquisitions result in a significant amount of goodwill.

Note 5. Goodwill and Other Intangible Assets

During 2013 and 2012 you recorded out of period corrections of tax adjustments for TransCore and iTrade. Please explain in further detail each of the adjustments made to your financial statements, including a discussion of how you became aware of the errors, the periods the adjustments relate to, and the prior and current accounting for each of these adjustments.

The Company respectfully informs the Staff that the tax adjustments for both iTrade and TransCore related to deferred income tax balances that were recorded on each acquired entity's pre-acquisition balance sheet and were erroneously included on each acquired entity's post-acquisition opening balance sheet. Such adjustments were deemed immaterial due to their size and balance-sheet-only impacts.

The TransCore acquisition occurred in 2004 and the adjustment was discovered in 2013. The Company became aware of this adjustment during a data review associated with a software implementation project. During this review, the Company discovered that a deferred income tax liability that was recorded on TransCore's pre-acquisition balance sheet for a cumulative temporary difference relating to goodwill was also included on TransCore's post-acquisition opening balance sheet. Since there should be no cumulative temporary difference on TransCore's opening balance sheet for goodwill, the deferred income tax liability was incorrectly stated which caused TransCore's goodwill balance to be overstated.

The iTrade acquisition occurred in 2010 and the adjustment was discovered in 2012. The Company became aware of this adjustment during our provision-to-return true-up process when the Company compared the calculated tax effect of iTrade's cumulative temporary differences to the existing deferred income tax account balances. During this review, the Company determined that certain pre-acquisition deferred income tax balances were not properly eliminated from iTrade's post-acquisition opening balance sheet. iTrade's deferred income tax liability balance was therefore incorrectly stated on its opening balance sheet which resulted in an overstatement of iTrade's goodwill balance.

Note 7. Income Taxes

In note 1 of your financial statements you disclose that the amount of earnings of foreign subsidiaries that you consider are permanently reinvested was approximately $939 million at December 31, 2013. This amount was approximately $1.05 billion at December 31, 2012 as shown in note 1 of your 2012 10-K. Additionally, in note 7 in your 2013 10-K your deferred tax assets related to foreign tax credits decreased from $20.3 million at December 31, 2012 to $425,000 at December 31, 2013. Please address the following:

·	Explain to us the circumstances that led to the decrease in unremitted earnings and foreign tax credits, including the amount of repatriations to the U.S., and the amount of foreign tax credits used during 2013;

The Company respectfully informs the Staff that it did not repatriate any unremitted prior year earnings to the U.S. in 2013, and that the decrease in unremitted earnings was the result of a review performed in 2013 on the methodology used to calculate the cumulative outside basis differences in the stock of its controlled foreign corporations ("CFCs"). As a result of this review, the Company determined the outside stock basis difference it reported at December 31, 2012 was overstated. The overstatement was due to the exclusion of lower-tier CFC earnings deficits which the Company believes should have been aggregated with top-tier CFC earnings, with an effect of $275 million. The remaining difference between 2012 and 2013 is $165 million of unremitted earnings that the Company's CFCs generated in 2013.

The Company's deferred tax assets related to foreign tax credits decreased from $20.3 million at December 31, 2012 to $0.425 million at December 31, 2013 substantially due to provision to return true-ups and anticipated utilization of foreign tax credit carryforwards on the 2013 U.S. tax return.

·	To the extent you remitted earnings during 2013, please tell us how you determined that the remittance of foreign earnings did not impact your current or future assertions regarding permanent reinvestment.

The Company respectfully informs the Staff that it did not repatriate any earnings in 2013 from our foreign entities with respect to which we have made the indefinite reinvestment assertion.

Form 8-K dated January 27, 2014

Exhibit 99.1

As required by Instruction 2 to Item 2.02 of Form 8-K, we see that you present the reconciliation required by Item 10(e)(1)(i) of Regulation S-K for your non-GAAP financial information in the form of an "adjusted" income statement. Please tell us how your presentation considers the guidance set forth in Compliance and Disclosure Interpretation 102.10. Under the cited guidance, it is generally not appropriate to present a non-GAAP income statement for purposes of reconciling non-GAAP measures to the most directly comparable GAAP measures.

In response to the Staff's comment, the Company respectfully advises the Staff that, in designing the table reconciling GAAP measures to non-GAAP measures that is the subject of the Staff's comment (the "Reconciliation Table"), the Company considered the guidance set forth in Compliance and Disclosure Interpretation 102.10 and the Staff's view that a full non-GAAP income statement is generally inappropriate, but believes that the Reconciliation Table provides additional, useful disclosure to investors without attaching undue prominence to the non-GAAP financial information contained therein.

However, the Company acknowledges that including almost all of the income statement line items could be interpreted as presenting a financial statement. In future presentations, we will remove items which do not specifically require reconciliation. As an example, the noted disclosure from our Form 8-K dated January 27, 2014 would be presented going forward as follows:

	2013
GAAP revenue	$	3,238,128
Sunquest adjustment to acquired deferred revenue		6,980
MHA accounting adjustment to revenue		26,433
Adjusted revenue	$	3,271,541

Reconciliation of GAAP diluted earnings per share to Adjusted diluted earnings per share
	2013
GAAP earnings	$	538,293
Sunquest adjustment to acquired deferred revenue		6,980
MHA accounting adjustment to revenue		26,433
Special related to vendor component		9,100
Related tax effect of adjustments		(14,880	)
Adjusted earnings	$	565,926

Diluted share outstanding		100,209
GAAP diluted earnings per share	$	5.37
Adjusted diluted earnings per share	$	5.65

Reconciliation of GAAP operating margin to Adjusted operating margin
	2013
GAAP income from operations	$	842,361
Sunquest adjustment to acquired deferred revenue		6,980
MHA accounting adjustment to revenue		26,433
Special related to vendor component		9,100
Adjusted income from operations	$	884,874

GAAP revenue	$	3,238,128
GAAP operating margin		26.0	%

Adjusted revenue	$	3,271,541
Adjusted operating margin		27.0	%

* * * *

In connection with the Company's response to the comments of the Staff set forth herein, the Company acknowledges the following:

·	the Company is responsible for the adequacy and accuracy of the disclosure in the filing;

·	Staff comments or changes to disclosure in response to Staff comments do not foreclose the Commission from taking any action with respect to the filing; and

·	the Company may not assert Staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

____________________

Please address any comments or questions with respect to the foregoing to the undersigned at (941) 556-2616.

Very truly yours,

/s/ John Humphrey

John Humphrey

cc: David B. Liner, Esq.

Roper Industries, Inc.

PricewaterhouseCoopers LLP

Bruce K. Dallas, Esq.

Davis Polk & Wardwell LLP